CIK 0001723128
- Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 908-947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
- 4 Open-market buy Director bought 353,649 shares at an average $2.74 ($970,344)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Co-CEO and Director bought 100,000 shares at $3.09 ($309,000)
- 4 Open-market buy President, Co-CEO & Director bought 100,000 shares at $3.09 ($309,000)
- 4 Open-market buy President, Co-CEO & Director bought 250,000 shares at an average $3.90 ($974,958)
- 4 Open-market buy Director bought 150,000 shares at an average $3.93 ($589,073)
- 4 Open-market buy Co-CEO and Director bought 250,000 shares at an average $3.90 ($974,942)
- 4 Shares withheld for taxes SVP, Chief HR Officer gave up 4,228 shares (to pay taxes)
- 4 Shares withheld for taxes Exec VP, Comm Optns gave up 6,683 shares (to pay taxes)
- 4 Open-market buy SVP, Specialty Commercial bought 40,000 shares at $3.62 ($144,800)
- 4 Derivatives Options or other derivatives
Page 12 of 18 · 351 filings